Patents Assigned to LAIMU CORPORATION
  • Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
    Patent number: 11911417
    Abstract: A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: February 27, 2024
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai
  • Method for improving eye conditions
    Patent number: 11759483
    Abstract: Disclosed is a method for improving eye conditions comprising orally administering to humans, an ethanol-soluble component-containing degradation product obtained by degrading a comb with a protease and removing a solid.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: September 19, 2023
    Assignee: LAIMU CORPORATION
    Inventor: Sachio Wakayama
  • Composition and method for producing the same
    Patent number: 11564950
    Abstract: A degradation product produced by degrading a composition containing a hyaluronic acid and a protein with a protease has a pain relieving effect, a joint function ameliorating effect, a cholesterol-lowering effect, a hypoglycemic effect and a diastolic blood pressure-lowering effect.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: January 31, 2023
    Assignee: LAIMU CORPORATION
    Inventor: Sachio Wakayama
  • Compound, anti-allergy drug, and mediator release inhibitor
    Patent number: 11345675
    Abstract: A compound represented by the following formula has a high anti-allergy activity. R1 represents a substituted or unsubstituted acyloxy group, or a substituted or unsubstituted acylamino group, R2 represents a substituted or unsubstituted alkyl group.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 31, 2022
    Assignee: LAIMU CORPORATION
    Inventors: Akihiro Tai, Kaori Miura, Sachio Wakayama
  • Nerve growth promoter
    Patent number: 11246849
    Abstract: The nerve growth promoter of the invention contains a valine in which the hydrogen atom of the amino group may be substituted with a substituent. The nerve growth promoter of the invention has a high effect of promoting differentiation of stem cells into nerve cells and formation of neurites in nerve cells, and the active ingredient therein is hardly degraded by digestive enzymes.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: February 15, 2022
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai, Takeru Koga
  • Method for producing protease degradation composition
    Patent number: 11179414
    Abstract: Disclosed is a method for producing a protease degradation composition by degrading a composition containing a hyaluronic acid and a protein with a protease, in the presence of an ascorbic acid, an ascorbate or a salt thereof. The composition produced according to the method has a high fibroblast proliferation promoting effect and a high collagen production promoting effect.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: November 23, 2021
    Assignee: LAIMU CORPORATION
    Inventor: Sachio Wakayama
  • Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
    Patent number: 10973858
    Abstract: A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: April 13, 2021
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai